dc.contributor.author | Loktev, A | |
dc.contributor.author | Shipley, JM | |
dc.date.accessioned | 2020-05-26T10:44:55Z | |
dc.date.issued | 2020-04-02 | |
dc.identifier.citation | Expert opinion on therapeutic targets, 2020, 24 (4), pp. 281 - 285 | |
dc.identifier.issn | 1472-8222 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3631 | |
dc.identifier.eissn | 1744-7631 | |
dc.identifier.doi | 10.1080/14728222.2020.1738392 | |
dc.format | Print-Electronic | |
dc.format.extent | 281 - 285 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | TAYLOR & FRANCIS LTD | |
dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
dc.title | Desmoplastic small round cell tumor (DSRCT): emerging therapeutic targets and future directions for potential therapies. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2020-03-02 | |
rioxxterms.versionofrecord | 10.1080/14728222.2020.1738392 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
rioxxterms.licenseref.startdate | 2020-04 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Expert opinion on therapeutic targets | |
pubs.issue | 4 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Sarcoma Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Molecular Pathology | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Sarcoma Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Molecular Pathology | |
pubs.publication-status | Published | |
pubs.volume | 24 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Sarcoma Molecular Pathology | |
dc.contributor.icrauthor | Shipley, Janet | |